Showing results (161-170 of 609) with videos related to
Sort By:
Pageof 61
The Journal of Urology|July 24, 2012
Causes of death after radical prostatectomy at a large tertiary centerJohn Bernard Eifler, Elizabeth B Humphreys, Marilyn Agro, et al.Urologic Oncology|September 9, 2010
External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy seriesStacy Loeb, Gustavo F Carvalhal, Donghui Kan, et al.European Urology Focus|October 5, 2019
Impact of the Internet on Patient-Physician CommunicationAisha T Langford, Timothy Roberts, Jaytin Gupta, et al.The Journal of Urology|March 27, 2007
The association between total prostate specific antigen concentration and prostate specific antigen velocityXiaoying Yu, Stacy Loeb, Kimberly A Roehl, et al.Journal of Endourology|July 13, 2024
Quality of Information About Kidney Stones from Artificial Intelligence ChatbotsDavid Musheyev, Alexander Pan, Abdo E Kabarriti, et al.The Journal of Urology|April 21, 2018
Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical ProstatectomyHiten D Patel, Mohit Gupta, Jeffrey J Tosoian, et al.The Journal of Urology|November 17, 2009
Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?Stacy Loeb, Kimberly A Roehl, Brian T Helfand, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate CancerStacy Loeb, Yasin Folkvaljon, Jan-Erik Damber, et al.Urology|July 8, 2008
Management of distal ureter in laparoscopic nephroureterectomy--a comprehensive review of techniquesAmanda M Macejko, Joseph F Pazona, Stacy Loeb, et al.BJU International|February 3, 2012
Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancerStacy Loeb, E Jeffrey Metter, Donghui Kan, et al.Pageof 61